Sort
48,018 grants matching “immunotherapy”
Molecular basis of receptor-ligand recognition in the Immunological Synapse
$542,750Andras Fiser · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · GM
Molecular basis of receptor-ligand recognition in the Immunological Synapse
$542,750Andras Fiser · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · GM
Molecular basis of receptor-ligand recognition in the Immunological Synapse
$542,750Andras Fiser · Albert Einstein College Of Medicine · R01 · FY2019 · GM
Engineering ferritin degrader-encapsulated platelets for post-surgical TNBC treatment
$542,721Quanyin Hu · University Of Wisconsin-Madison · R01 · FY2024 · EB
Whitlockite nanoparticle-based immunotherapy for bone metastasis
$542,721Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2021 · CA
Engineering ferritin degrader-encapsulated platelets for post-surgical TNBC treatment
$542,721Quanyin Hu · University Of Wisconsin-Madison · R01 · FY2025 · EB
Bifunctional T cell receptor based immunotherapeutics
$542,687Altor Bioscience Corporation · R44 · FY2004 · CA
Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes
$542,641Ramon Francisco Barajas · Oregon Health & Science University · R37 · FY2025 · CA
Neurologic Alterations in Alzheimer's Disease
$542,628Bradley T Hyman · Massachusetts General Hospital · R01 · FY2010 · AG
Phase II Trial of HOKT3gamma 1 (ALA-ALA) in Type 1 Diabetes
$542,608Kevan C Herold · Yale University · R01 · FY2010 · DK
Regulatory T Cell Function in Ovarian Cancer
$542,599Kirsten B Moysich · Roswell Park Cancer Institute Corp · R01 · FY2013 · CA
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy
$542,592Allon Moshe Klein · Harvard Medical School · R01 · FY2020 · CA
Biomaterials for modulating the gut microbiome for immune activation
$542,526James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Tcf1 programs CD8 T cell responses to enhance viral and cancer immunity
$542,495Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2020 · AI
Oncolytic Immunotherapy using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
$542,479James M Markert · University Of Alabama At Birmingham · R01 · FY2019 · CA
Targeting Alloreactivity for Leukemia Eradication
$542,432Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2010 · CA
Chemokine interaction with CXCR4 and ACKR3: structure and activation mechanisms
$542,393Tracy M Handel · University Of California, San Diego · R01 · FY2019 · GM
Chemokine interaction with CXCR4 and ACKR3: structure and activation mechanisms
$542,393Tracy M Handel · University Of California, San Diego · R01 · FY2017 · GM
Lung-brain coupling and the immune response to acute ischemic stroke
$542,350Marc W Halterman · State University New York Stony Brook · R01 · FY2021 · NS
CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity
$542,314Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2022 · AI
Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma
$542,305Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Unraveling the Pathophysiology of Neurotoxicity Induced by CAR T-cells
$542,294Christopher A Pennell · University Of Minnesota · R01 · FY2022 · CA
Unraveling the Pathophysiology of Neurotoxicity Induced by CAR T-cells
$542,294Christopher A Pennell · University Of Minnesota · R01 · FY2025 · CA
Small Circular mRNA Vaccines
$542,272Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2024 · AI
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
$542,252Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA